HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Heart Failure


The Practical Cardiology(TM) Heart Failure clinical resource center is an information hub for the latest in heart failure and heart failure management. With a focus on heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF) this page features content including articles, videos, podcasts, and clinician-authored columns on FDA approvals, studies, guideline updates, and more.

Torsemide Provides No Benefit Over Furosemide for Mortality, Hospitalization in Heart Failure

November 05, 2022

Results of the TRANSFORM-HF trial presented at AHA 22 indicate there were no significant differences in rate of all-cause mortality or hospitalization with the use of torsemide compared with furosemide in people with heart failure.

COVID-19 Donor Hearts Still Viable for Transplantation, Study Finds

October 31, 2022

An analysis of data from the United Network for Organ Sharing database, which included the first 84 COVID-19-positive heart transplants, indicates hearts from COVID-19-positive donors were still viable for transplant and not associated with increased risk of organ failure rate, risk of postoperative stroke or dialysis, and 30-day mortality.

Cardiology Month in Review: October 2022

October 29, 2022

The October 2022 cardiology month in review features the top content from HFSA 2022, new data related to antithrombotic therapy in atrial fibrillation, and shining a spotlight on the AHA’s scientific statement on patient-reported outcomes in peripheral artery disease.

County-Level Food Insecurity Linked to Increased Heart Failure Mortality Rates

October 26, 2022

An analysis of data from more than 2900 counties in the US is providing clinicians with new insight into the impact of social determinants of health, namely food insecurity, might influence heart failure mortality rates on a population level across the US.

Black Patients with Heart Failure Half as Likely to Receive Device Therapy, Transplant as White Patients

October 19, 2022

Despite no differences in patient preferences, an analysis from the National Institutes of Health suggests Black patients with heart failure were 55% less likely than their White counterparts to receive a ventricular assist device or transplantation.

8-in-10 Medicare Beneficiaries Hospitalized with HFpEF Could be Considered Candidates for Dapagliflozin

October 04, 2022

An analysis applying data from the DELIVER trial to the Get With The Guidelines-Heart Failure Registry suggests 81% of hospitalized Medicare beneficiaries with HFpEF could be considered candidates for dapagliflozin use under a potential FDA label expansion.